Cargando…

Dexamethasone/remdesivir: Lack of efficacy and off-label use: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051794/ http://dx.doi.org/10.1007/s40278-022-14118-y

Ejemplares similares

Dexamethasone/remdesivir: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone/remdesivir: Lack of efficacy and off-label use: case report
Publicado: (2021)

Dexamethasone/remdesivir: Lack of efficacy and off label use: case report
Publicado: (2021)

Dexamethasone/remdesivir: Lack of efficacy and off-label use: case report
Publicado: (2021)

Apixaban/dexamethasone/remdesivir: Off-label use and lack of efficacy: case report
Publicado: (2022)

Dexamethasone/remdesivir/tocilizumab: Off-label use and lack of efficacy: case report
Publicado: (2022)

Dexamethasone/remdesivir/tocilizumab: Lack of efficacy and off label use: case report
Publicado: (2021)

Dexamethasone/methylprednisolone/remdesivir: Off-label use and lack of efficacy: case report
Publicado: (2021)

Aciclovir/dexamethasone/remdesivir: Lack of efficacy following off-label use: case report
Publicado: (2022)

Dexamethasone/enoxaparin-sodium/remdesivir: Lack of efficacy and off label use: case report
Publicado: (2022)

Dexamethasone/enoxaparin-sodium/remdesivir: Lack of efficacy following off-label use: case report
Publicado: (2021)

Dexamethasone/remdesivir/rituximab: Hypotension, dyspnoea and lack of efficacy following off-label use: case report
Publicado: (2021)

Antithymocyte-globulin/dexamethasone/remdesivir: COVID-19, lack of efficacy and off-label use: 2 case reports
Publicado: (2021)

Dexamethasone/insulin/remdesivir: Lack of drug effect and off label use: 2 case reports
Publicado: (2021)

Remdesivir/tocilizumab: Lack of efficacy and off-label use: case report
Publicado: (2022)

Methylprednisolone/remdesivir: Lack of efficacy and off-label use: case report
Publicado: (2021)

Convalescent-anti-sars-cov-2-plasma/dexamethasone/remdesivir: Lack of efficacy and off label use: case report
Publicado: (2022)

Dexamethasone: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone: Lack of efficacy and off-label use: case report
Publicado: (2022)

Antibacterials/interferon/remdesivir: Lack of efficacy and off-label use: case report
Publicado: (2021)

Convalescent-anti-SARS-CoV-2-plasma/dexamethasone/remdesivir: Off-label use and lack of efficacy: case report
Publicado: (2021)

Antibacterials/dexamethasone/remdesivir: Lack of efficacy: case report
Publicado: (2022)

Dexamethasone/remdesivir/tocilizumab: Lack of efficacy: case report
Publicado: (2022)

Dexamethasone/remdesivir/tocilizumab: Methaemoglobinaemia and off-label use: case report
Publicado: (2021)

Dexamethasone/methylprednisolone: Off label use and lack of efficacy: case report
Publicado: (2022)

Dexamethasone: Lack of efficacy following off-label use: case report
Publicado: (2022)

Dexamethasone/tocilizumab: Off-label-use and lack of efficacy: case report
Publicado: (2021)

Gilteritinib/hydroxycarbamide/remdesivir: Neutropenia, lack of efficacy and off-label use: case report
Publicado: (2021)

Dexamethasone/remdesivir: Lack of efficacy and drug withdrawal: case report
Publicado: (2022)

Remdesivir: Sinus bradycardia and lack of efficacy following off-label use: 4 case reports
Publicado: (2022)

Dexamethasone/tocilizumab: Lack of efficacy during off label use: case report
Publicado: (2022)

Dexamethasone/meropenem: Infections, off label use and lack of efficacy: case report
Publicado: (2022)

Ciprofloxacin/corticosteroids/dexamethasone: Lack of efficacy and off-label use: case report
Publicado: (2022)

Antibacterials/corticosteroids/dexamethasone: Lack of efficacy and off-label use: case report
Publicado: (2021)

Dexamethasone/remdesivir: Sinus bradycardia and off label use in COVID-19 and :case report
Publicado: (2021)

Azithromycin/ceftriaxone/remdesivir: Bradycardia and lack of efficacy following off-label use: 2 case reports
Publicado: (2022)

Remdesivir: Elevated ALT level and lack of efficacy following off-label use: 13 case reports
Publicado: (2021)

Ceftriaxone/dexamethasone/levofloxacin: Lack of efficacy following off-label use: case report
Publicado: (2022)

Dexamethasone/piperacillin/tazobactam: Lack of efficacy following off-label use: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3ouqi8jj79mnrk56dpu70fi2q8